ロード中...
A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22
A unique feature of rheumatoid arthritis (RA) is the presence of anti-citrullinated protein antibodies (ACPA). Several risk factors for RA are known to increase the expression or activity of peptidyl arginine deiminases (PADs), which catalyze citrullination and, when dysregulated, can result in hype...
保存先:
| 出版年: | JCI Insight |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070957/ https://ncbi.nlm.nih.gov/pubmed/27777982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.90045 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|